https://doi.org/10.4081/aamr.2019.65
Prevalence of human immunodeficiency, hepatitis B and hepatitis C viruses among antenatal care attendees in Bauchi State, Nigeria
Published: July 30, 2019
Abstract Views: 53
PDF: 23
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) are blood borne viral infection with huge disease burden on pregnant women and their babies especially in Bauchi, Nigeria. Data on the prevalence rates of these infections would aid the clinical management and public health control of these infections. The study determined the prevalent rates of HIV, HBV and HCV among ante-natal care (ANC) attendees in health facilities in Bauchi State, north-eastern Nigeria. This is a a descriptive study that reviewed data secondarily from 13 health facilities in Bauchi State, Nigeria. Data were collected for a 12-month period from July 2017 - June 2018. The study found the following average prevalence rates among the ANC attendees: HIV (0.71%), HBV (1.57%) and HCV (0.64%). The study found low but significant prevalent rates of HIV, HBV and HCV infections among the ANC attendees. The study recommends for strengthening of preventive and curatives measures against these viruses among the pregnant women. These include health education, HBV vaccination, anti-retroviral therapy and early diagnosis and treatment of these viruses. The study also recommends for appropriate, complete and consistent medical records to monitor these viruses. Further studies are required for the HIV, HBV and HCV infections and their co-infections among the pregnant women.
Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006;44:S6-9.
Chang CC, Crane M, Zhou JL, et al. HIV and co-infections. Immunol Rev 2013;254:114-42.
Centers for Disease Control and Prevention. HIV/AIDS and Viral Hepatitis. Division of Viral Hepatitis and National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 2018. Available from: https://www.cdc.gov/hepatitis/populations/hiv.htm
Modjarrad K, Vermund SH. Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis 2010;10:455-63.
Centers for Disease Control and Prevention. HIV and Viral Hepatitis.. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. 2017. Available from: https://www.cdc.gov/hiv/pdf/library/factsheets/hiv-viralhepatitis.pdf
Rockstroh JK. Influence of viral hepatitis on HIV infection. J Hepatol 2006;44:525-7.
Chandra N, Joshi N, Raju YSN, et al. Hepatitis B and/or C coinfection in HIV infected patients: A study in a tertiary care center from south India. Indian J Med Res 2013;138:950-4.
Benhammou V, Tubiana R, Matheron S, et al. HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes. J Acquir Immune Defic Syndr 2018;77:439-50.
Ahmad I. Prevalence of Hepatitis B and C Viral Infection Among Pregnant Women in Peshawar, Pakistan, Hepat Mon 2016;16:e36383.
Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. The Lancet 2015;386:1546-55.
Hanafiah KM, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013;57:1333-42.
World Health Organisation. HIV/AIDS: HIV and Hepatitis coinfections. 2018. Available from: http://www.who.int/hiv/topics/hepatitis/en/
Umego CF, Mboto CI, Mbim EN, et al. Epidemiology of Hepatitis B Virus Infection in South-South, Nigeria: A Review. Int STD Res Rev 2018;7:1-17.
Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ. Seroprevalence of hepatitis B and C infection among the HIVpositive population in Abuja, Nigeria. Afr Health Sci 2012;12:312-7.
Odjimogho S, Agofure O, Okandeji-Barry ORA, Ibrahim ZL. Prevalence of hepatitis B and C among HIV/AIDS patients attending Bingham University Teaching Hospital Jos Plateau State Nigeria: A retrospective study. J Publ Health Epidemiol 2018;10:198-204.
Mohammed AI, JY, Okwong OK, Umar MS. Seroprevalence of HBV, HCV and HIV Among Voluntary Blood Donors at a Tertiary Hospital in Bauchi, Northeastern Nigeria. EJPMR 2017;4:80-85.
Jibrin YB, Kolo PM, Mohammed A, et al. Burden of hepatitis B and C infections among pregnant women in Bauchi, Northeastern Nigeria. Sub-Saharan Afr J Med 2016;3:188-93.
Center for Disease Control and Prevention. Principles of Epidemiology in Public Health Practice, Third Edition An Introduction to Applied Epidemiology and Biostatistics. 2012. Available from: https://www.cdc.gov/ophss/csels/dsepd/ss1978/lesson3/section2.html
Wasley A, Alter M. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000;20:1-16
Perz JF, Farrington LA, Pecoraro C, Hutin YJF, Armstrong G.L. Estimated global prevalence of hepatitis C virus infection. In: Abstracts of the Infectious Diseases Society of America 42nd annual meeting, Boston, MA, September 2004.
Duru MU, Aluyi HSA, Anukam KC. Rapid screening for coinfection of HIV and HCV in pregnant women in Benin City Edo State, Nigeria. Afr Health 2009;9:137-42.
Centre for Disease Control and Prevention Blood borne Infectious Diseases: Hiv/Aids, Hepatitis B, Hepatitis C. 2016. Available form: http://www.cdc.gov/niosh/topics/ bbp/genres.html.
Favour O, Onah VO, Anikwe VC. Sero-epidemiology of Human Immunodeficiency Virus (HIV), Hepatitis B and C among pregnant women in Rural Communities of Abaji Area Council, Nigeria. TAF Prev Med Bull 2012;11:431-8.
Chanu I, Auwalu U, Muhammad Y, et al. Epidemiological Study of HCV and HIV Infections in Relation to Certain Demographic Factors Among the Ante-Natal Population Within Kaduna Metropolis, Nigeria. Int J Infect Dis Ther 2016;1:13-21.
Obi RK, Umeh SC, Okurede OH, Iroagba II. Prevalence of hepatitis B virus infection among pregnant women in an antenatal clinic in Port Harcourt, Nigeria. Afr J Clin Exp Microbiol 2006;7:78-82.
Mc Mahon BJ, Alward WL, Hall DB. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985;151:599-603.
Kiire CF. The epidemiology and Prophylaxis of hepatitis B in Sub-Saharan Africa:A review from tropical and subtropical Africa. Gut 1996;38:5-12.
Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ. Sero-prevalence of hepatitis B and C infection among the HIVpositive population in Abuja, Nigeria. Afr Health Sci 2012;12:312-7.
Olokoba AB, Salawu FK, Danburam A, et al. Hepatitis B virus infection amongst pregnant women in North-Eastern Nigeria - A call for action. Nig J Clin Pract 2011;14:10-3.
Buseri FI, Seiyaboh E, Jeremiah ZA. Surveying Infections among pregnant women in the Niger Delta, Nigeria. J Global Infect Dis 2010;2:203-11.
Oluboyo BO, Ugochukwu VI, Olubuyo AO, et al. Prevalence of Hepatitis B and C Viral infections in pregnant women attending ante-natal Clinic in Nnewi, Nigeria. Eur Sci J 2014;10:434-41.
How to Cite
Mustapha, D. M., Alami-Adhama, A. A., Hussaini, I., Dambam, S. M., Faruk, B. M., Titus, O., … Ibrahim, M. A. (2019). Prevalence of human immunodeficiency, hepatitis B and hepatitis C viruses among antenatal care attendees in Bauchi State, Nigeria. Annals of African Medical Research, 2(1). https://doi.org/10.4081/aamr.2019.65
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.